SPEAKER NAME /
Samia Mora, MD, MHS
Time of Talk
This webcast will review how Lp(a), a genetically derived LDL-like-particle, can increase cardiovascular risk.
Institutional research grant to the Brigham and Women’s Hospital from Atherotech Diagnostics (2018).
Quest Diagnostics measured Lp(a) in the JUPITER trial.
This enduring material activity, Should We Measure Lipoprotein(a) and What Should We Do With the Results?, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins July 1, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.